BMO Capital Adjusts Ventas Price Target to $53 From $51
Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and American Healthcare REIT, Inc. (AHR)
J.P. Morgan Sticks to Their Hold Rating for Healthpeak Properties (DOC)
American Healthcares Analyst Ratings
JMP Securities Reiterates Market Outperform on American Healthcares, Maintains $16 Price Target
Ventas Analyst Ratings
Healthcare Realty Trust Analyst Ratings
Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23
Welltower Analyst Ratings
American Healthcare REIT: Balanced Operational Strength and Strategic Portfolio Management Amid Cautious Hold Rating
Healthpeak Properties Analyst Ratings
Scotiabank Adjusts Price Target on Welltower to $108 From $96
JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating
Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating
JMP Securities Sticks to Their Buy Rating for American Healthcare REIT, Inc. (AHR)
Sabra Health Care REIT Analyst Ratings
Morgan Stanley Adjusts Price Target on Welltower to $103 From $102
Buy Rating for Strawberry Fields REIT: Solid Growth and Strategic Acquisitions
Analysts Are Bullish on Top NA Stocks: American Healthcare REIT, Inc. (AHR), PACS Group Inc (PACS)
Medical Properties Trust Analyst Ratings